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In this report, we investigate the role of the RNA-binding protein HuR during skeletal myogenesis. At the
onset of myogenesis in differentiating C2C12 myocytes and in vivo in regenerating mouse muscle, HuR cyto-
plasmic abundance increased dramatically, returning to a predominantly nuclear presence upon completion of
myogenesis. mRNAs encoding key regulators of myogenesis-specific transcription (myogenin and MyoD) and
cell cycle withdrawal (p21), bearing AU-rich regions, were found to be targets of HuR in a differentiation-
dependent manner. Accordingly, mRNA half-lives were highest during differentiation, declining when differ-
entiation was completed. Importantly, HuR-overexpressing C2C12 cells displayed increased target mRNA
expression and half-life and underwent precocious differentiation. Our findings underscore a critical function
for HuR during skeletal myogenesis linked to HuR’s coordinate regulation of muscle differentiation genes.
Skeletal muscle cells have proven to be an excellent model
system for defining the molecular mechanisms involved in the
decision between continued proliferative growth and tissue
differentiation (27). During muscle differentiation, proliferat-
ing myoblasts permanently withdraw from the cell cycle and
fuse to become postmitotic, multinucleated myotubes with a
contractile phenotype that will ultimately mature into myofi-
bers (29). These morphogenic changes are accompanied by
specific alterations in the patterns of muscle-specific genes
expressed (27). Particularly important among them are two
groups of transcription factors: the MyoD family, comprising
MyoD, Myf5, myogenin, and myogenic regulatory transcrip-
tion factor 4 (MRF-4), and the myocyte enhancer factor-2
family (28). In turn, these proteins regulate the transcription of
muscle-specific genes required to establish myoblast identity
and control their terminal differentiation. MyoD and Myf5 are
expressed in proliferating myoblasts, while increased abun-
dance of myogenin and p21 (cyclin-dependent kinase inhibi-
tor) marks a stage in which myoblasts are destined for fusion
and terminal differentiation into myotubes (12, 35, 36). Regen-
erating adult muscle shares many features of embryonic muscle
differentiation. Adult muscle fibers express undetectable levels
of MRFs, except for MRF4, but MRF expression is induced
during injury-induced skeletal muscle regeneration. The in
vivo expression of MyoD and myogenin during regeneration is
similar to that observed in developing limbs (16). Skeletal
muscle regeneration after injury is characterized by the prolif-
eration and differentiation of muscle precursor cells, followed
by their fusion to form new or restored myofibers. A tight
regulation of differentiation and regeneration is therefore crit-
ical for the production of functional muscle.
Transcriptional as well as posttranscriptional mechanisms
critically contribute to regulating gene expression patterns dur-
ing cellular processes such as proliferation, differentiation, the
stress response, immune cell activation, growth arrest, and cell
death. Among posttranscriptional events, mRNA turnover is
emerging as a critical paradigm of gene regulation (13, 31, 32).
Even small differences in mRNA half-life can rapidly alter
its abundance and, consequently, the amount of protein ex-
pressed. The mechanisms determining mRNA turnover, gen-
erally believed to involve RNA-binding proteins that recognize
specific RNA sequences, have become the focus of intense
investigation in recent years. Best characterized among the
RNA sequences influencing mRNA stability are AU-rich ele-
ments (AREs), usually found in the 3 untranslated region
(UTR) of labile mRNAs (11, 42), such as those encoding
cytokines (interferon and interleukins), cell cycle regulatory
genes (p21, cyclin A, cyclin B1, and cdc25 genes), growth
factors (granulocyte-macrophage colony-stimulating factor
and vascular endothelial growth factor), apoptosis-related
genes (bcl-2), and proto-oncogenes (c-fos and c-myc). While
many RNA-binding proteins have been described that selec-
tively recognize and bind to AREs, their influence on mRNA
turnover is best known for the embryonic lethal abnormal
vision (ELAV) and AUF1 proteins (7, 24, 43).
Initially described in Drosophila melanogaster, ELAV pro-
tein was found to be essential for proper differentiation of the
nervous system (9). Genetic, molecular, and biochemical stud-
ies have suggested that ELAV’s mammalian counterparts may
likewise participate in regulating tissue growth and differenti-
ation. HuR is expressed ubiquitously, while HuC and HuD are
specifically expressed in neuronal tissues and HuB is expressed
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in neuronal tissues and in testes and ovaries (2, 7). Several
recent reports support a role for ELAV proteins in neuronal
differentiation in mammalian systems. In rat PC12 cells, over-
expression of HuB, HuC, or HuD induced neuronal differen-
tiation features such as neurite outgrowth in the absence of
nerve growth factor, while diminished HuD expression re-
duced neurite outgrowth in the presence of NGF (1, 21).
ELAV proteins possess three RNA recognition motifs that
mediate binding with high affinity and specificity to ARE-
containing target mRNAs (7). ELAV proteins have been re-
ported to target mRNAs encoding proteins important for dif-
ferentiation (i.e., neurofilament N and GAP-43 [2, 3, 5, 33])
and for growth and proliferation (i.e., p21, cyclin A, cyclin B1,
c-fos, and VEGF) by increasing their stability, translation, or
both (14, 19, 20, 25, 37).
The precise mechanisms whereby HuR mediates mRNA
stabilization are still poorly understood. HuR is predominantly
localized in the nucleus of most unstimulated cells but can
translocate to the cytoplasm upon cell stimulation, a process
that has been linked to the stabilization of many target mRNAs
(14, 15, 22, 30, 37). The association of HuR with PP32, APRIL,
and SET/ proteins is believed to influence HuR export from
the nucleus and possibly also to modulate HuR’s affinity for its
target mRNAs (8). Although PP32 and SET/ are known to
inhibit protein phosphatase 2A, AMP-activated kinase is the
only kinase thus far directly implicated in the regulation of
HuR cytoplasmic levels and the consequent stabilization of
HuR target mRNAs (40).
In the present investigation, we study the role of HuR in
myogenesis using in vitro and in vivo models. HuR was almost
exclusively nuclear in actively proliferating, undifferentiated
C2C12 myoblasts, but it became strikingly abundant in the
cytoplasm upon induction of differentiation by insulin, trans-
ferrin, and selenium (ITS), remained elevated in the cytoplasm
for the duration of the differentiation process, and returned to
a predominantly nuclear presence upon the completion of cell
differentiation. Similarly, in an animal model of skeletal muscle
regeneration, which largely resembles embryonic muscle dif-
ferentiation, cytoplasmic HuR increased in regenerating myo-
fibers, declining upon completion of the process. These events
coincided temporally with the expression of myogenin and
MyoD. During C2C12 cell differentiation, HuR was found to
target mRNAs encoding myogenin, p21, and MyoD, all of
them being pivotal regulators of muscle cell differentiation;
such increased association was linked to increased stability
of the corresponding mRNAs. Importantly, overexpression of
HuR in C2C12 cells increased the expression and half-life of
target mRNAs and accelerated C2C12 differentiation. We pro-
pose that HuR plays a critical role in myogenesis in vitro and
in vivo.
MATERIALS AND METHODS
Cell culture and transfection. C2C12 murine myoblasts were cultured in Dul-
becco’s modified Eagle’s medium (DMEM) containing 20% fetal bovine serum
and antibiotics (Gibco-BRL, Gaithersburg, Md.). To induce differentiation, cells
(80 to 90% confluence) were cultured in DMEM containing ITS for up to 5 days
(120 h). Transient transfection of C2C12 cells with pEGFP-HuR (37) was carried
out using Lipofectamine (Invitrogen, Carlsbad, Calif.) for 5 h. After removal of
the transfection medium, cells were incubated in either 10% fetal bovine serum
or serum-free DMEM containing ITS for the times indicated.
Nuclear run-on, Northern blot, and Western blot analyses. Northern blot
analysis from C2C12 cells was carried out by using standard procedures. Probes
were prepared with [-32P]dATP by either random-primed labeling of PCR-
amplified fragments corresponding to the coding regions of myogenin, MyoD,
and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or by end labeling of
oligonucleotides recognizing the 18S rRNA (used to monitor the loading and
transfer of Northern blot samples) and mouse p21 mRNA (17). For mRNA
half-life assessments, actinomycin D (ActD) (2.5 g/ml) was added, and total
RNA was prepared at the times indicated. mRNA half-lives were calculated after
measurement of Northern blot signals, normalization to 18S signals, plotting on
logarithmic scales (line graphs), and calculation of the time required for a given
transcript to be reduced to half of its initial signal intensity (bar graphs). Nuclear
run-on assays were carried out as previously described (13, 17), using 1 g of
purified PCR product per slot.
For Western blotting, cytoplasmic and nuclear fractions were prepared as
described previously (37). Twenty micrograms of whole-cell protein, 10 g of
cytoplasmic lysate, and 10 g of nuclear lysate were routinely utilized for West-
ern blot analysis. After transfer, membranes were hybridized with antibodies
recognizing either HuR (monoclonal anti-HuR antibody, Molecular Probes,
Eugene, Oreg.), myogenin (monoclonal antibody from Developmental Studies
Hybridoma Bank, Baltimore, Md.), -tubulin (monoclonal antibody from On-
cogene Research Products, San Diego, Calif.), histone deacetylase 8 and MyoD
(Santa Cruz), or myosin heavy chain (Developmental Studies Hybridoma Bank,
Iowa City, Iowa). Following incubation with the appropriate secondary antibod-
ies, signals were detected using enhanced chemiluminescence (Amersham Phar-
macia Biotech).
In vitro transcription. DNA templates for in vitro transcription of various
regions of the myogenin, p21, and MyoD mRNAs were synthesized by PCR using
reverse transcribed cDNA, except for myogenin, which was prepared using plas-
mid pEMSV-myogenin as template. All 5 primers contained the T7 RNA
polymerase promoter (T7, CCAAGCTTCTAATACGACTCACTATAGGGA
GA). For amplification of the myogenin coding region (GenBank no. D90156),
encompassing nucleotides 387 to 719, primers used were T7-GCTGCCTAAAG
TGGAGATC and GGAAGGCAACAGACATATC; for amplification of the
myogenin 3 UTR (encompassing positions 769 to 1471), the primers used were
T7-GCCATCACTTCTGTAGCAG and GATATCAACCAGTCTTTATTC.
For amplification of the MyoD coding region (GenBank no. NM010866), en-
compassing positions 261 to 831, the primers used were T7-GAGACAGCAGA
CGACTTCTATG and CGCTGTAATCCATCATGCCATC; for amplification
of the MyoD 3 UTR, encompassing positions 1241 to 1762, the primers used
were T7-GACACTCTTCCCAACTGTCC and GCACTACACAGCATGCCT.
p21 fragments were amplified as reported previously (37). All PCR templates
were purified from agarose gels. RNA transcripts were synthesized using T7
RNA polymerase in the presence of either [-32P]UTP or biotinylated CTP and
purified as described previously (37, 38).
Binding assays: RNase T1 selection, agarose gel shift assay, UV cross-linking,
RNA electrophoretic mobility shift assay (REMSA), and supershift REMSA.
Glutathione S-transferase (GST) and GST-HuR were prepared as described
previously (20). Reaction mixtures (20 l) contained 50 mM Tris-HCl [pH 7.0],
0.25 mg of tRNA/ml, 0.25 mg of bovine serum albumin/ml, 10 to 20 fmol of
labeled RNA (100,000 to 600,000 cpm), and purified GST or GST-HuR. After 10
min of incubation at 37°C, 5 U of RNase T1 was added to each reaction for an
additional 10 min. Reaction mixtures were filtered through nitrocellulose, and
bound HuR-RNA complexes were extracted with phenol-chloroform. RNA was
then precipitated, dissolved in formamide, denatured (65°C, 2 min), and size
separated by 10% polyacrylamide–50% urea gel electrophoresis. Gels were dried
and exposed to film. Agarose gel shift assays were done as described previously
(20).
For UV cross-linking assays, REMSAs, and supershift REMSAs, binding
reactions and electrophoresis to visualize complexes were carried out as previ-
ously described (37). For supershift assays, 0.5 g of either anti-HuR or anti-p38
antibodies (Santa Cruz) was used.
Immunofluorescence. Cells were fixed in cold methanol. Endogenous HuR
was visualized in samples incubated with anti-HuR antibody (Molecular Probes)
and then with fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse
immunoglobulin G (IgG; 115-095-003; Jackson Laboratories). Enhanced green
fluorescent protein (EGFP) and chimeric EGFP-HuR (37) were visualized di-
rectly. Confocal microscopy was performed with a Bio-Rad Laboratories MRC-
1024 laser scanning microscope equipped with an Axiovert 100 microscope
(ZEISS) at an excitation wavelength of 488 nm.
Biotin pull-down. Binding of proteins (40 g of cytoplasmic lysate) to biotin-
ylated transcripts (2 g) was performed in the presence of RNase inhibitor (5
Prime33, Prime, Inc., Boulder, Colo.) for 30 min at room temperature. Com-
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plexes were isolated with paramagnetic streptavidin Dynabeads (Dynal, Oslo,
Norway) for 30 min, washed with phosphate-buffered saline, and subjected to
Western blot analysis to detect HuR.
Analysis of muscle regeneration in mice. Prior to injury, mice (C57BL/6, 8 to
12 weeks old) were anesthetized by an intraperitoneal injection of dormicum and
droperidol. Regeneration of skeletal muscle was induced by intramuscular in-
jection of 400 l of 10 M cardiotoxin (Latoxan, France), as described previously
(10), in the right gastrocnemius muscle, using contralateral intact muscles as
control. Morphological and biochemical examinations were performed at 0, 0.4,
3, 9, and 20 days after injury, using three animals per time point. For Western
blotting, gastrocnemius muscles were dissected, sectioned, weighed, and
pounded in an ice-cold Potter tube containing 0.1 mM Tris-HCl [pH 7.6], 2 mM
EDTA, and 0.4% Triton X-100; extracts were centrifuged for 20 min at 4°C at
12,000  g, and supernatants were used for Western blotting. For histological
analysis, after cervical dislocation of the mice, muscles were removed, dissected,
frozen in liquid nitrogen, and stored at 80°C prior to sectioning. Transverse
cryostat sections (10 m thick) were stained with hematoxylin-eosin (HE) to
visualize cellular structures. Endogenous HuR was visualized by immunofluo-
rescence as described above.
IP of endogenous HuR-mRNA complexes. The association of endogenous
HuR with endogenous mRNAs encoding myogenin, MyoD, and p21 was as-
sessed in C2C12 cells undergoing differentiation using a method previously
described (34). Twenty million C2C12 cells were collected per time point, and
lysates were used for immunoprecipitation (IP) for 4 h at room temperature in
the presence of excess (30 g) immunoprecipitating antibody (either a mouse
monoclonal anti-HuR antibody, 3A2 [a generous gift of J. A. Steitz], or an IgG1
isotype control antibody [B&D Life Sciences]). RNA in IP material was used in
reverse transcription-PCR (RT-PCR) to detect the presence of mRNAs encod-
ing myogenin, MyoD, and p21 using Superscript One-Step RT-PCR system
(Invitrogen). Primer pairs for PCR amplification of the coding regions of myo-
genin and MyoD mRNAs are described above; amplification of the mouse p21
mRNA (GenBank no. U24173) encompassing positions 26 to 737 was performed
using primers TGTCAGAGTCTAGGGGAATTGG and AGGTTTGGAGAC
TGGGAGAG. PCR amplification was carried out as follows: 1 min at 94°C, 1
min at 55°C, and 1 min at 68°C, for 20 cycles (myogenin) or 24 cycles (MyoD,
p21). PCR products were visualized on 1.5% agarose gels by ethidium bromide
staining.
RESULTS
C2C12 muscle cell differentiation is associated with in-
creased stabilization of mRNAs encoding myogenin, MyoD,
and p21. The mouse myoblast cell line C2C12 has been used
extensively to study muscle cell differentiation (27). As shown
in Fig. 1A, treatment with ITS causes actively proliferating,
undifferentiated myoblasts to differentiate into distinct myo-
tubes, a process lasting approximately 5 days (120 h). In keep-
ing with previous reports (29), myogenin expression changed
dramatically throughout the differentiation period (Fig. 1B). In
order to investigate the extent to which its expression was
controlled through altered transcription, we carried out nu-
clear run-on analysis (Fig. 1C); myogening gene transcription
was elevated at the late times examined. Given the relatively
modest transcriptional increase of myogenin expression
(eightfold) and the robust ITS-triggered induction in myo-
genin mRNA (	70-fold), we hypothesized that mRNA stabi-
lization might act in concert with increased transcription to
achieve the strong induction in myogenin expression (Fig. 1).
Examination of the myogenin mRNA revealed a relatively
long 3 UTR containing AREs (depicted as shaded regions in
Fig. 3A, below). Given that AREs are linked to changes in
mRNA stability, we set out to investigate whether myogenin
expression was regulated through altered mRNA turnover dur-
ing ITS-triggered C2C12 cell differentiation. First, we carried
out measurements of myogenin mRNA half-life using ActD-
based assays. Briefly, at various times after ITS addition (0, 4,
8, 12, 24, 48, and 120 h), ActD was added to block new mRNA
transcription, and RNA was prepared at successive times there-
after (0, 1, 2, 4 h, etc). Northern blot analysis served to monitor
the rate of clearance of the myogenin transcript (Fig. 1D) and
thus calculate the myogenin mRNA half-life at various times
following addition of ITS. The myogenin mRNA half-life var-
ied throughout the differentiation period: it increased during
the early stages of differentiation, having an apparent half-life
of 2.5 h at the first time point examined (4 h after addition of
ITS), a half-life of 5 h at 8 h of ITS treatment, and a half-life
of 10.5 h at 12 h of ITS treatment. Myogenin mRNA stability
appeared to be maximal at around 24 h into ITS-induced
differentiation, when its apparent half-life was greater than
20 h. At subsequent time points, the myogenin mRNA stability
declined, exhibiting a half-life of 7 h at 48 h into the differen-
tiation process and a half-life of 4 h by 120 h (5 days) of ITS
treatment, when differentiation was complete and myotubes
were formed.
Several other genes that are known to participate in myocyte
differentiation also bear AREs in their 3 UTRs. Two such
genes, namely, the p21 and MyoD genes, were found to encode
mRNAs that displayed similar alterations in stability through-
out the differentiation process. As shown in Fig. 2A, p21 and
MyoD mRNA levels increased during the early phases of
C2C12 differentiation. MyoD mRNA half-life appeared to be
maximal (4.5 h) at 24 h into differentiation, while p21 mRNA
half-life seemed to reach its greatest value (12 h) at 48 h of
differentiation; in each case, mRNA stability declined thereaf-
ter (Fig. 2B). In summary, the stability of mRNAs encoding
key differentiation-associated genes increased during the early
stages of differentiation of C2C12 myocytes.
The 3 UTRs of myogenin, MyoD, and p21 are HuR targets
during C2C12 muscle cell differentiation. The mechanisms
underlying the stabilization of mRNAs encoding these three
differentiation-associated genes were further investigated by
examining whether these mRNAs were targets of RNA-bind-
ing proteins that could alter their stability in a differentiation-
regulated manner. To this end, different regions of each cDNA
were amplified by PCR using 5 primers that contained the T7
RNA polymerase promoter sequence. PCR-generated tem-
plates were used for in vitro synthesis of transcripts corre-
sponding to various regions of myogenin, MyoD, and p21
mRNAs (Fig. 3A; see Materials and Methods). Radiolabeled
transcripts corresponding to either the coding region or the 3
UTR of myogenin, MyoD, and p21 were incubated with cyto-
plasmic lysates from C2C12 cells undergoing differentiation.
As shown in Fig. 3B, the myogenin 3 UTR transcript, but not
a transcript encompassing its coding region, formed complexes
with proteins present in cytoplasmic lysates of C2C12 cells;
such complexes were readily detectable by REMSA. Com-
pared with cytoplasmic proteins from untreated cells, cytoplas-
mic proteins from cells undergoing differentiation produced
markedly more abundant binding to myogenin 3 UTR. In-
creased association with cytoplasmic proteins was also seen
when using the MyoD 3 UTR and p21 3 UTR probes. Of
note, the MyoD 3 UTR transcript was poorly digested by
RNase T1, presumably due to the extensive secondary struc-
ture of this RNA. Despite our best efforts, much radiolabeled
transcript remained undigested after incubation with RNase
T1, even in control samples without lysate (Fig. 3B, lane f),
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FIG. 1. Myogenin expression and mRNA stability are altered during differentiation of C2C12 muscle cells. (A) Asynchronously growing C2C12
cells (top) were subjected to differentiation using ITS. After 120 h (5 days) in continuous presence of ITS, cultures were fully differentiated and
displayed abundant myotubes (bottom). (B) Top, Northern blot analysis of myogenin expression in C2C12 cells undergoing differentiation. 18S
rRNA signals served to control for RNA loading. The graph depicts myogenin mRNA signal intensities (relative to 18S signals) shown as the means

 standard errors of the means from three independent Northern blot analyses. Bottom, Western blot analysis of myogenin expression in C2C12
cells undergoing differentiation for the times indicated. All lanes on the Western blot were loaded equally. (C) Nuclear run-on analysis to monitor
transcription in C2C12 cells undergoing differentiation for the time periods shown. Nascent, radiolabeled RNA was hybridized to 1 g of PCR-
generated and slot blotted cDNAs; pUC19 plasmid was included as control for nonspecific hybridization. (D) Assessment of myogenin mRNA
stability during C2C12 cell differentiation. mRNA half-lives were calculated after treatment of cells with 2.5 g of ActD/ml and preparation of
RNA at the times indicated; myogenin mRNA signals were measured, normalized to 18S rRNA signals, and plotted on a logarithmic scale.
Horizontal dashed lines, 50% of untreated. Data represent the means 
 standard deviations from three experiments. Bar graphs depict mRNA
half-life values during C2C12 differentiation.
4994 FIGUEROA ET AL. MOL. CELL. BIOL.
hampering our ability to perform certain types of assays using
this transcript (see below). None of the transcripts encompass-
ing coding regions formed discernible complexes with proteins
present in cytoplasmic lysates (Fig. 3B and previously reported
results for p21 [37]). As shown earlier for other treatment
conditions and transcripts (37, 39), REMSA using nuclear ly-
sates and radiolabeled 3 UTR transcripts revealed extensive
binding in each case, but binding was unaffected by C2C12 cell
differentiation (Fig. 3B). In conclusion, the 3 UTRs of these
three mRNAs were bound by cytoplasmic proteins from
C2C12 cells in a differentiation-dependent manner.
Next, we sought to identify the cytoplasmic protein(s) form-
ing complexes with the 3 UTR transcripts of myogenin,
MyoD, and p21. RNA-protein complexes forming with ra-
diolabeled transcripts were cross-linked and visualized after
sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
Several complexes were readily visible, with some forming ir-
respective of the cell differentiation stage and others exhibiting
FIG. 2. Half-lives of mRNAs encoding the MyoD and p21 muscle differentiation-associated genes change during C2C12 myocyte differenti-
ation. (A) Northern blot analysis of MyoD, p21, and GAPDH expression in C2C12 cells undergoing differentiation for the times shown. The graph
depicts the intensities of mRNAs encoding p21 and MyoD (relative to 18S), shown as the means 
 standard errors of the means from three
independent Northern blot analyses. (B) The stability of mRNAs encoding MyoD, p21, and GAPDH was calculated as explained in the legend
for Fig. 1D.
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a differentiation-induced pattern. Among the latter group was
a single common band appearing with all three transcripts,
with a size of approximately 36 to 38 kDa (Fig. 3C). We
hypothesized that this band corresponded to the RNA-binding
protein HuR based on the following facts: (i) HuR is 36 kDa,
(ii) HuR has high affinity for AREs akin to those existing in the
3 UTRs of myogenin and MyoD, (iii) HuR and other ELAV
proteins have been reported to play an important role in the
differentiation of neuronal tissues, and (iv) HuR binds the p21
mRNA (37). To test this possibility directly, recombinant GST
or GST-HuR was incubated with radiolabeled myogenin tran-
scripts and then subjected to RNase T1 selection assays (see
Materials and Methods). After filtering through nitrocellulose,
protected fragments were seen only after incubation of the
myogenin 3 UTR’s transcript with GST-HuR, but not after
incubations containing either GST or a transcript correspond-
ing to the myogenin coding region (Fig. 3D). Radiolabeled
myogenin 3UTR and GST-HuR formed complexes that could
also be visualized in agarose gel retardation assays (Fig. 3E).
In order to assess whether endogenous HuR bound these
target mRNAs, we performed supershift REMSA analysis with
cytoplasmic lysates from differentiating C2C12 cells and radio-
labeled transcripts encompassing the 3 UTRs of myogenin
and p21. REMSA complexes increased during the early phases
of differentiation and declined at the completion of differen-
tiation (120 h), returning to the levels seen in untreated cells
(Fig. 4A). The presence of HuR in REMSA complexes was
ascertained by supershift analysis using an anti-HuR antibody.
As shown in Fig. 4A, such analysis revealed that HuR was
indeed present in the radiolabeled complexes, and the abun-
dance of supershifted complexes increased in a differentiation-
dependent manner (although it is important to note that su-
pershift REMSA analyses are not strictly quantitative). The
specificity of the supershifted bands was confirmed through use
of a control antibody recognizing the mitogen-activated pro-
tein kinase p38, which failed to supershift radiolabeled com-
plexes. Given that the MyoD 3 UTR transcript was poorly
digested by RNase T1 (Fig. 3B), we were unable to perform
supershift REMSA for this mRNA. Therefore, in order to
ascertain whether the MyoD 3 UTR was a target of HuR, we
used two alternative approaches, as described below.
First, the association of HuR with these target mRNAs was
assessed using biotinylated transcripts encompassing the re-
gions indicated (Fig. 4B). After incubation with cytoplasmic
lysates of C2C12 cells undergoing differentiation, biotinylated
RNAs encompassing the 3 UTRs of myogenin, MyoD, and
p21 effectively pulled down HuR, as detected by Western blot
analysis (see Materials and Methods). As shown, association of
HuR with biotinylated transcripts was very low in untreated
cultures, increased with cell differentiation, and decreased
upon completion of differentiation. Control biotinylated tran-
scripts, such as an RNA encompassing the myogenin coding
region (and other coding regions, not shown), did not pull
down HuR (Fig. 4B). Second, we examined the binding of
endogenous HuR to endogenous mRNAs encoding myogenin,
MyoD, and p21 in C2C12 cells. IP of HuR and associated
endogenous mRNAs was tested using either a monoclonal
anti-HuR antibody (3A2) or an isotype-matched IgG1 (Fig.
4C), and the IP material was assessed for presence of myoge-
nin, MyoD, and p21 mRNAs by RT-PCR (see Materials and
Methods). As shown in Fig. 4D, the three transcripts were
remarkably abundant in material obtained from IP using anti-
HuR antibody but were either undetectable or much less abun-
dant (at 0 h for MyoD and 6 h for MyoD and p21) in IP
material obtained with a control, isotype-matched IgG1. More-
over, binding of HuR to its target mRNAs increased as C2C12
cell differentiation progressed.
It is important to note the existence of lag time between the
detection of HuR binding to target transcripts, which occurs
very rapidly (Fig. 3 and 4), and the increase in the specific
target transcript’s half-life, which reaches its maximum by 12 to
24 h (Fig. 1 and 2). For example, it is possible that HuR
binding to a target RNA does not by itself cause immediate
mRNA stabilization and may require transport to a particular
subcellular compartment or association with another cellular
factor(s).
Together, these findings demonstrate that HuR associates
with mRNAs encoding myogenin, MyoD, and p21 in vitro and
in vivo in a differentiation-dependent manner and that this
association increases during the early stages of differentiation
and decreases upon completion of the differentiation process.
The cytoplasmic abundance of HuR increases dramatically
during C2C12 cell differentiation. The evidence gathered thus
far supports the association of transcripts encoding myogenin,
MyoD, and p21 with HuR in the cytoplasms of differentiating
C2C12 cells. Given extensive evidence linking HuR’s cytoplas-
mic localization with its mRNA-stabilizing function (7, 22, 37),
it was of particular interest to investigate the subcellular local-
ization of HuR throughout the differentiation process. West-
ern blot analysis using whole-cell lysates revealed a moderate
FIG. 3. In vitro binding of HuR to the myogenin 3UTR. mRNAs encoding myogenin, MyoD, and p21 form complexes with C2C12 cytoplasmic
proteins in a time-dependent fashion. (A) Schematic representation of the mRNAs encoding myogenin, MyoD, and p21, and various transcripts
corresponding to the coding region and 3 UTR used in this study. Boxes, RNA sequences of the 3 UTR transcripts used; the p21 3 UTR probe
was previously reported (20). (B) REMSA detection of RNA-protein complexes. PCR-amplified cDNA fragments were used as templates to
synthesize 32P-radiolabeled RNA probes. Cytoplasmic and nuclear fractions (10 g each) prepared at the times indicated during C2C12
differentiation were assayed for binding to the indicated RNA probes. Complexes were resolved on 7% native polyacrylamide gels that were
subsequently dried and visualized with a PhosphorImager. Brackets indicate inducible RNA-protein complexes. f (free probe), radiolabeled RNA
incubated only with RNase T1. (C) Cytoplasmic fractions prepared from differentiating C2C12 cells were incubated with myogenin, MyoD, and
p21 3 UTR transcripts, and the resulting radiolabeled complexes were digested with RNase T1 and subjected to UV cross-linking and
electrophoresis through sodium dodecyl sulfate-containing 15% polyacrylamide gels. Upon drying of gels, signals were visualized using a Phos-
phorImager. Numbers denote sizes (in kDa) of molecular weight markers (MWM). Open arrowheads, radiolabeled complexes; black arrowheads,
predicted position of HuR. (D) An RNase T1 selection assay was carried out using myogenin transcripts and 10 nM either GST or GST-HuR. T1,
digestions with RNase T1 alone. Arrowhead, protected RNA fragments. (E) Agarose gel retardation assays using myogenin 3 UTR and the
indicated concentrations of either GST or GST-HuR. Arrowhead, protected RNA fragments.
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FIG. 4. Endogenous HuR forms differentiation-dependent complexes with recombinant and endogenous transcripts encoding myogenin,
MyoD, and p21. (A) Complexes forming with cytoplasmic lysates from C2C12 cells undergoing differentiation for the times indicated and the
radiolabeled transcripts shown were assayed for their ability to be supershifted by 0.5 g of either anti-HuR antibody (HuR) or a control
antibody recognizing the mitogen-activated protein kinase p38 (p38). Arrowheads, HuR-containing supershifted complexes. (B) Biotinylated
transcripts corresponding to the 3 UTRs of each mRNA, as well as the myogenin coding region (CR) (negative control), were incubated with
cytoplasmic C2C12 lysates prepared at the times shown after induction of differentiation. Complexes were pulled down using streptavidin-
conjugated magnetic beads, and HuR abundance was analyzed by Western blotting. (C) HuR in C2C12 lysates after IP using either anti-HuR
antibodies (3A2) or isotype-matched IgG1 was assessed by Western blot analysis (WB) of the IP material. (D) The presence of HuR target mRNAs
encoding myogenin, MyoD, and p21 was assessed by RT-PCR analysis of IP material obtained using either anti-HuR or control IgG1 antibodies.
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increase in HuR expression during the early stages of differ-
entiation (by 24 h in ITS); it declined slightly by day 5 (120 h)
(Fig. 5A). However, when subcellular fractions were tested,
HuR abundance increased remarkably in C2C12 cytoplasms at
the onset of differentiation, remained elevated during differ-
entiation, and decreased to almost undetectable levels upon its
completion (Fig. 5A). The nuclear abundance of HuR did not
fluctuate noticeably throughout differentiation (Fig. 5A).
These alterations in HuR’s subcellular localization were not
due to overall increased expression of HuR, but likely resulted
from elevated cytoplasmic transport of HuR, as previously
reported (4, 14, 15, 22, 30, 37). Despite the striking changes in
cytoplasmic HuR, a correspondingly marked reduction in nu-
clear HuR was not seen. This is explained by the relative
abundance of HuR in each cellular compartment: in untreated
C2C12 cells, HuR is about 10-fold more abundant in the nu-
cleus, so even substantial elevations in cytoplasmic HuR pro-
duce little change in the nuclear HuR pool. Western blotting of
the same membranes to detect nucleus- and cytoplasm-specific
proteins (histone deacetylase 8 and -tubulin, respectively)
verified that nuclear proteins did not leak into the cytoplasmic
fractions during cell treatment or fractionation and further
monitored the even loading and transfer of samples (Fig. 5A).
Analysis of histone deacetylase and -tubulin was routinely
performed on all Western blots containing subcellular frac-
tions. Immunohistochemical analysis of HuR expression cor-
roborated these observations. HuR was almost exclusively
nuclear in untreated C2C12 cultures, but ITS treatment
caused HuR cytoplasmic abundance to increase dramatically at
early time points (6 h) and to remain elevated through 24 and
FIG. 5. Effect of C2C12 cell differentiation on the subcellular localization of HuR. (A) Western blot analysis of HuR levels in cytoplasmic (10
g), nuclear (10 g), and whole-cell (20 g) lysates prepared from C2C12 cells that were undergoing differentiation for the times indicated.
(B) Immunofluorescence detection of HuR in C2C12 cells throughout the differentiation process. Magnification, 40; zoom, close-up images.
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48 h of ITS treatment. HuR returned to a predominantly
nuclear localization when differentiation ended (120 h) (Fig.
5B).
Cytoplasmic HuR increases markedly during skeletal mus-
cle regeneration in vivo. The results described thus far suggest
a link between HuR and myogenesis using an in vitro model. In
order to ascertain whether HuR might be involved in skeletal
myogenesis in vivo, we investigated HuR expression and sub-
cellular localization using a mouse model of muscle regenera-
tion. Muscle damage was induced by intramuscular injection of
cardiotoxin, and the expression of HuR was investigated in the
regenerating muscle at different times postinjury. Injury-in-
duced muscle regeneration was monitored morphologically
and by Western blot analysis of muscle samples prepared be-
fore injury and 3 and 9 days after injury. As shown, MyoD,
myogenin, and the developmental isoform of myosin heavy
chain (MHCd, whose expression is restricted to developing
muscle in embryos and neonates and to regenerating muscle in
adults and which serves as a regeneration marker here) were
undetectable in uninjured muscle, increased dramatically 3
days after injury, and returned to basal levels after 9 days,
indicating that regeneration was proceeding normally (Fig.
6A). In order to investigate the expression and subcellular
localization of HuR during the regeneration process, cryosec-
tions of regenerating muscle at different times postinjury were
analyzed by immunofluorescence using an anti-HuR antibody
(Fig. 6B). HuR was detectable in the nuclei of uninjured myo-
fibers (along the periphery) but not in the cytoplasm of unin-
jured myofibers. However, HuR expression in the cytoplasm of
myofibers increased markedly as early as 6 h after cardiotoxin
injection. The most dramatic increase in the cytoplasmic abun-
dance of HuR was seen by 3 days after injury, a time when
muscle is actively involved in regeneration. Evidence for on-
going regeneration was apparent in HE-stained preparations,
FIG. 6. Cytoplasmic localization of HuR after induced injury in mouse muscle. (A) Muscle lysates from either intact (0 days postinjury [d.p.i.])
or cardiotoxin-injured muscles (3 and 9 d.p.i.) were prepared for Western blot analysis to assess the expression of regeneration markers MyoD,
myogenin, and MHCd, as well as loading control -tubulin. (B) Immunofluorescent detection of HuR in frozen muscle sections prepared at the
indicated d.p.i. Sections were stained with HE to monitor adequate progression of the degeneration-regeneration process. Magnification, 60.
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which exhibited fibrotic infiltrates and inflammatory cells
within the enlarged space between myofibers as well as new,
small myofibers (Fig. 6B). The heightened cytoplasmic local-
ization of HuR detected on day 3 postinjury coincided with the
robust expression of MyoD, myogenin, and MHCd (Fig. 6A).
By 9 and 20 days postinjury, as muscle regeneration ap-
proached completion, HuR was no longer detectable in the
cytoplasm of injured myofibers, and expression of MyoD, myo-
genin, and MHCd was concomitantly reduced (Fig. 6). The
changes in subcellular localization of HuR seen during muscle
regeneration parallel those observed in differentiating C2C12
cells and further support a physiological role for HuR during
myogenesis.
HuR directly contributes to the implementation of C2C12
differentiation. Strong correlations have thus emerged be-
tween HuR cytoplasmic presence during myogenesis, HuR’s
association with target mRNAs encoding myocyte differentia-
tion genes, and the altered stability of target mRNAs during
the C2C12 differentiation. Therefore, we set out to directly
assess whether HuR was directly implicated in regulating the
expression of differentiation-associated genes and hence the
differentiation of C2C12 myoblasts. We overexpressed HuR
through transient transfection (Fig. 7A, EGFP-HuR) and ex-
amined the expression of target mRNAs by Northern blotting.
As shown, steady-state levels of mRNAs encoding myogenin,
MyoD, and p21 were higher in cells expressing elevated levels
of HuR (EGFP-HuR) than in control, pEGFP-transfected
populations (Fig. 7B). This finding is in keeping with numerous
examples in which overexpression of HuR resulted in height-
ened stability of target mRNAs resulting in their increased
expression (reviewed in reference 7). Indeed, the half-lives of
mRNAs encoding myogenin, MyoD, and p21 increased in cells
overexpressing HuR (Fig. 7C).
More importantly, cells overexpressing HuR were capable of
forming myotubes earlier in the differentiation process. In
EGFP-HuR-expressing C2C12 cells, proportionately more fu-
sion protein was found in the cytoplasm of untreated cultures,
but further regulation of its subcellular localization was similar
to that of endogenous HuR (not shown). Consequently, in this
population, EGFP-positive early myotubes (two- to four-cell
fusions) were readily observed by 16 h after transfection, be-
fore addition of ITS, and further increased after addition of
ITS (Fig. 7D and E). By contrast, no myotubes were seen in
control populations transfected with an EGFP-expressing plas-
mid, although these cells differentiated at the normal pace,
with EGFP-positive myotubes beginning to appear 8 h after
triggering differentiation by ITS (Fig. 7D and E). Taken to-
gether, our studies reveal that HuR is a critical regulator of the
expression of key muscle differentiation-associated genes. We
propose that it is through its influence on such genes that HuR
has a direct impact on myogenesis.
DISCUSSION
In this study, we provide evidence that expression of myo-
genin, MyoD, and p21 during muscle cell differentiation is
subject to regulation through altered mRNA turnover, and we
implicate the RNA-binding protein HuR in this process. At the
onset of differentiation, the striking increase in steady-state
levels of ARE-bearing mRNAs encoding myogenin, MyoD,
and p21 was shown to be due to increased transcript stability.
Through a series of binding assays using recombinant as well as
endogenous proteins, HuR was identified as a major protein
binding to the 3 UTRs of these mRNAs in vitro and to the
corresponding endogenous mRNAs in vivo (Fig. 3 and 4).
Moreover, the differentiation-dependent associations of HuR
with its target mRNAs were found to occur in the cytoplasm of
C2C12 cells, the subcellular compartment where HuR is be-
lieved to exert its mRNA-stabilizing influence (for review, see
reference 7). HuR abundance in C2C12 cytoplasms increased
prominently upon induction of myocyte differentiation, re-
mained elevated during the early stages of differentiation, and
decreased towards the end of the differentiation period, re-
turning to an almost exclusive nuclear presence when myo-
tubes were formed. Similarly, in an in vivo myogenesis model,
injury-induced skeletal muscle regeneration in the mouse also
caused a dramatic upregulation of cytoplasmic HuR in regen-
erating myofibers, coinciding with the de novo expression of
myogenic proteins myogenin and MyoD. In support for the
hypothesis that HuR regulates the stability of target myogenic
mRNAs during muscle cell differentiation were the findings
that each mRNA was stabilized with kinetics that coincided
with HuR’s cytoplasmic presence and that overexpression of
HuR enhanced their steady-state levels and half-lives. Impor-
tantly, HuR overexpression accelerated the onset of C2C12
differentiation. We postulate that HuR can hasten muscle dif-
ferentiation through its ability to upregulate the expression of
critical differentiation regulatory genes.
As with skeletal muscle development during embryogenesis,
a tight control of proliferation and differentiation during skel-
etal muscle regeneration is required for the production of
functional muscle tissue after injury. For example, MyoD is
required for satellite cell function in adult skeletal muscle;
accordingly, MyoD-deficient mice develop a severe deficiency
in their ability to regenerate skeletal muscle (26). Based on our
in vitro data supporting HuR’s role on the expression of MyoD
and myogenin in differentiating C2C12 cells, it is plausible that
in vivo, HuR also regulates the stability of myogenic regulators
MyoD and myogenin, which are essential for skeletal muscle
regeneration.
Our findings support a role for HuR in coordinately regu-
lating the expression of several genes that play pivotal roles in
the establishment or maintenance of differentiated muscle tis-
sue. Previous studies by our group and others have demon-
strated HuR’s role in coordinating the expression of collections
of genes involved in the same cellular process. For example,
HuR jointly influenced the expression of cyclin A and cyclin B1
during the cell division cycle by coordinately stabilizing their
respective mRNAs during the proliferative phases (38). Simi-
larly, maintenance of a “young” cell phenotype in models of in
vitro senescence was found to rely on HuR-mediated stabili-
zation of several mRNAs encoding proliferative proteins such
as cyclin A, cyclin B1, and c-fos (39). The cellular response to
stresses such as exposure to UV light likewise causes coordi-
nate changes in the stability of several stress-response genes,
like the p21 and gadd153 genes (our unpublished observa-
tions), as well as other gadd genes (the gadd34, gadd45,
gadd33, and gadd7 genes [18]) and several immediate-early
genes, such as c-fos, c-jun, and c-myc (6). Given HuR’s in-
creased function by UV (37) and its ability to bind to mRNAs
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encoding synchronously regulated genes, HuR may effectively
serve as a common endogenous regulator of stress-response
gene expression at a posttranscriptional level. In this capacity,
the role of HuR within the cellular UV response is akin to that
of transcription factors such as activating protein-1, for exam-
ple, which coordinately increases the transcription of stress-
response genes (41).
A more systematic analysis to identify targets of the HuR-
related protein HuB during neuronal differentiation of P19
cells was undertaken by Tenenbaum et al. (33). IP of HuB
along with HuB-bound target mRNAs, followed by cDNA ar-
ray hybridization, revealed the existence of subsets of mRNAs
whose expression was coordinately regulated at a posttran-
scriptional level. These investigators have proposed that such
FIG. 7. Overexpression of HuR increases the expression of differentiation-associated genes and accelerates myotube formation. C2C12 cells
were transiently transfected with plasmids expressing either EGFP or EGFP-HuR. (A) Western blot analysis of HuR expression using whole-cell
lysates. (B) Quantitation of Northern blot signals to measure steady-state mRNA levels 16 h after transfection of either pEGFP or pEGFP-HuR
(10 h in the presence of ITS). (C) mRNA half-lives assessed 16 h after transfection (10 h in the presence of ITS), as explained in the legend for
Fig. 1D; data are the means of two similar experiments. (D) Following C2C12 transfection, the percentage of EGFP-positive cells forming syncytia
(two or more fused myocytes) was assessed in each transfection group. (E) Representative fields depicting early myotube formation in EGFP-
HuR-overexpressing C2C12 cells that were transiently transfected as described above. Cultures were examined by phase contrast (data not shown)
and fluorescence microscopy; syncytia are indicated with a white discontinuous line. Magnification, 40.
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en masse analysis of posttranscriptional mRNA regulation will
reveal functional connections between groups of genes that are
expressed jointly. They have termed this approach to func-
tional genomics “ribonomics” (34). The hypothesis underlying
their model is that mRNAs are organized into groups sharing
common functions and structural features. A common RNA-
binding protein could thus effectively regulate such function-
ally and structurally linked mRNA subpopulations during spe-
cific cellular processes such as proliferation, differentiation,
and the stress response. Keene, Tenenbaum, and coworkers
(23, 34) recently proposed that eukaryotic mRNA-protein as-
sociations play a role equivalent to that of operons. Prokaryotic
operons contain clustered genes that are expressed in single
polycistronic mRNAs; their coordinate expression thus allows
for efficient synthesis of functionally linked gene products nec-
essary for the organism’s response to changes in environmental
conditions. Such physical proximity of functionally related
genes is not normally seen in the genomes of higher eu-
karyotes. The proposed posttranscriptional operon model is
based on the presence of RNA regulatory elements, typically
present in the UTRs of eukaryotic mRNAs, and single RNA-
binding proteins that interact with such regulatory regions.
According to this model, the association of a given RNA-
binding protein with a group of mRNAs bearing a specific
regulatory sequence provides eukaryotic systems with the plas-
ticity and effectiveness to respond to stimuli of either endog-
enous or exogenous origin. The present investigation provides
evidence that HuR coordinately regulates a subset of genes
with critical functions during skeletal myogenesis, thereby
lending support to the posttranscriptional operon model.
In the future, it will be of interest to investigate the differ-
entiation process in C2C12 populations exhibiting reduced
HuR levels. Our efforts aimed at lowering HuR expression by
using antisense HuR-expressing vectors were unsuccessful due
to the poor transfectability of these cells and the detrimental
effects of low HuR levels on clonal cell growth (reference 40
and data not shown). Use of RNA interference caused all
transfected cells to become rounded and detach from the cul-
ture dish (not shown). While this observation is in keeping with
the notion that HuR contributes to establishing muscle differ-
entiation, further analysis of HuR’s role in myogenesis will
require the development of efficient approaches to reduce
HuR levels, such as mice in which HuR expression can be
knocked out in a conditional fashion.
How does the differentiation protocol cause HuR to in-
crease in the cytoplasm of C2C12 cells? Although this question
remains to be addressed experimentally, insulin is known to
stimulate glucose transport into a number of tissues, including
skeletal muscle. In turn, glucose availability causes cellular
ATP levels to rise, thereby lowering AMP/ATP ratios. Such
high-fuel conditions decrease the activity of the 5-AMP-acti-
vated kinase (AMPK) in the cell. It is important to note that
AMPK is the sole enzyme thus far identified as a regulator of
the cytoplasmic abundance of HuR; AMPK activation de-
creases cytoplasmic HuR levels, while AMPK inhibition effec-
tively elevates HuR’s cytoplasmic presence (40). The subcellu-
lar localization of HuR is believed to be controlled largely
through regulated nucleocytoplasmic transport involving the
HuR shuttling sequence, HNS (4, 14, 15, 22, 30, 37). Experi-
ments are under way to assess whether interventions to either
increase or decrease AMPK can alter the C2C12 differentia-
tion program and to assess the role of HuR in this process.
In summary, we have described a novel function for HuR as
a regulator of myogenesis. We postulate that HuR’s influence
on muscle cell differentiation is intimately linked to its cyto-
plasmic localization during the early stages of differentiation
and its ability to bind to and stabilize mRNAs that encode
critical muscle differentiation proteins. Our findings further
implicate HuR in the differentiation of muscle cells, under-
scoring HuR’s function within the global adaptive response to
changes in extracellular conditions. The present study provides
additional support for the role HuR plays as a major regulator
of gene expression in response to environmental cues.
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